New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2013
08:46 EDTOWW, DGIT, APP, MRK, AVNR, NQ, SINA, LLY, YUM, XRX, JCPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: NQ Mobile (NQ), up 10%... Sina (SINA), up 6.5%. ALSO HIGHER: Digital Generation (DGIT), up 38% after selling television ad delivery business for $485M, announcing plan to form new company that will hold DG's online business... Avanir Pharmaceuticals (AVNR), up 9% after announcing an agreement to co-promote Merck (MRK) therapies in U.S. long-term care institutions... Eli Lilly (LLY), up 4.3% after lung cancer drug met endpoint in trial... Xerox (XRX), up 3% following upgrade to Buy from Neutral at Citigroup... J.C. Penney (JCP), up 1.4% after Bill Ackman resigns from board. DOWN AFTER EARNINGS: American Apparel (APP), down 4.5%. ALSO LOWER: Yum! Brands (YUM), down 3.2% after announcing July same-store sales in its China division fell 13%, including a 16% drop at KFC stores... Orbitz Worldwide (OWW), down 12% after announcing PAR Capital Management has sold 8.1M of its 24.6M shares of Orbitz Worldwide stock.
News For JCP;XRX;YUM;LLY;SINA;NQ;AVNR;MRK;APP;DGIT;OWW From The Last 14 Days
Check below for free stories on JCP;XRX;YUM;LLY;SINA;NQ;AVNR;MRK;APP;DGIT;OWW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 5, 2014
16:45 EDTMRKMarket ends week little changed after mixed economic data
Subscribe for More Information
12:19 EDTAPPGap falls after reporting August same-store sales decline
Shares of apparel retailer Gap (GPS) are falling after the company reported disappointing August same-store sales results and Buckingham analysts downgraded the company's stock. WHAT'S NEW: Gap reported last night that its August comparable sales declined 2%, compared to a 2% increase a year ago in the same month. Gap Global SSS fell 9%, Banana Republic Global SSS fell 2% and Old Navy Global SSS rose 2%. Gap also reported its August net sales were flat compared to last year's $1.23B. WHAT'S NOTABLE: Looking ahead, the company said Gap's August sales performance will likely put pressure on the brand's gross margins in September. ANALYST REACTION: Gap was downgraded to Neutral from Buy at Buckingham this morning following the August comparable sales numbers. Buckingham analysts say they question the previously anticipated 2H14 comp recovery at the core brand and do not see upside to the stock if the flagship brand does not turn positive in the second half. Buckingham expects the stock's multiple to contract back to its historical average until sales improve. The firm still expects full-year 2014 guidance to be achievable as Gap manages expenses and it continues to like operational improvements the company is making in its supply chain and omni-channel initiatives. Until sales improve, Buckingham expects shares to remain range bound near $44 to $46. UBS analysts, on the other hand, say Gap's share weakness presents a buying opportunity. The firm said the miss does not derail the company's ability to show improvement over the second half and does not impact their long-term thesis tied to margin improvement opportunities. PRICE ACTION: Near noon, Gap fell $2.20, or about 5%, to $44.39. OTHERS TO WATCH: Competitors to Gap include American Apparel (APP), American Eagle (AEO), Urban Outfitters (URBN), Express (EXPR), and Abercrombie and Fitch (ANF).
11:17 EDTMRKBristol-Myers files patent infringement suit against Merck
Subscribe for More Information
08:39 EDTMRKMerck Keytruda sales to reach $5B in 2018, says BMO Capital
Subscribe for More Information
September 4, 2014
15:16 EDTMRKMerck receives accelerated approval of Keytruda
Subscribe for More Information
11:19 EDTYUMYum! shares pull back as company cuts Q3 China SSS view
Subscribe for More Information
09:06 EDTYUMOn The Fly: Pre-market Movers
UP AFTER EARNINGS: PVH Corp. (PVH), up 9%... Verifone (PAY), up 3.8%... Methode Electronics (MEI), up 13%... Bazaarvoice (BV), up 9%. ALSO HIGHER: Bolt Technology (BOLT), up 35.7% after Teledyne (TDY) agrees to acquire the company for $22 per share in cash... Mitek Systems (MITK), up 58% after USAA lawsuit settlement... Tibco Software (TIBX), up 7% after announcing that it is reviewing strategic alternatives... Stereotaxis (STXS), up 22% after receiving FDA clearance for Vdrive with V-Loop system... NewLink (NLNK), up 3.4% after reporting FDA approval for Phase 1 clinical studies of Ebola vaccine. DOWN AFTER EARNINGS: Ciena (CIEN), down 3%... Joy Global (JOY), down 1%... Matrix Service (MTRX), down 11%... Mobileye (MBLY), down 1.3%. ALSO LOWER: Yum! Brands (YUM), down 2.8% after updating third quarter China division same-store sales guidance... 3D Systems (DDD), down 2.9% after downgraded at Pacific Crest... GoPro (GPRO), down 3.5% after downgraded at JPMorgan... Shanda Games (GAME), down 4% after announcing reconstitution of special committee.
09:02 EDTMRKMerck's relebactam granted QIDP, fast track designations by FDA
Merck announced that the U.S. Food and Drug Administration has designated relebactam -- previously known as MK-7655 -- the company’s investigational beta-lactamase inhibitor, as a Qualified Infectious Disease Product with designated Fast Track status. The QIDP and Fast Track designations apply to intravenous use of relebactam for the treatment of complicated urinary tract infections, complicated intra-abdominal infections and hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia. Relebactam is an investigational, class A and C, beta-lactamase inhibitor that is being evaluated in combination with imipenem/cilastatin in ongoing Phase 2 clinical trials for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. In preclinical studies, relebactam administered in combination with imipenem/cilastatin demonstrated antibacterial activity against a broad range of Gram-negative and beta-lactam-resistant pathogens. Merck plans to initiate Phase 3 studies with relebactam in combination with imipenem/cilastatin in 2015.
08:59 EDTYUMYum! Brands risk/reward favorable at prospective levels, says RW Baird
Subscribe for More Information
08:11 EDTLLYEli Lilly's insulin peglispro for diabetes shows positive Phase III results
Subscribe for More Information
08:07 EDTYUMYum! Brands volatility expected to move on Q3 China division sales guidance
Yum! Brands volatility is expected to move after updating Q3 China division sales guidance. Overall option implied volatility of 18 is below its 26-week average of 23 according to Track Data, suggesting decreasing price movement.
08:01 EDTYUMYum! Brands consensus estimates still need to come down, says Morgan Stanley
Morgan Stanley said Yum! Brands pre-released China Q3 same-store-sale estimate of (13%) was well below consensus of +80bps. The firm said the news should not be a surprise given recent supplier issues but consensus estimates still remain too high and will need to come down. The analyst remains below consensus and sees no specific catalysts insight. Shares are Equal Weight rated.
07:56 EDTYUMYum! Brands price target lowered to $85 from $90 at UBS
Subscribe for More Information
07:21 EDTMRKMedidata can obtain major new platform customers, says Stifel
Noting that Medidata (MDSO) partners with Veeva, Stifel believes that a number of Veeva (VEEV) customers could become Medidata platform customers, especially if they already use Medidata for R&D and clinical trial solutions. The firm identifies Merck (MRK), Gilead (GILD), and Teva (TEVA) as companies that may become platform clients for Medidata. Stifel keeps a $55 price target and Buy rating on Medidata.
September 3, 2014
18:39 EDTYUMOn The Fly: After Hours Movers
UP AFTER EARNINGS: Bazaarvoice (BV), up 8%... PVH Corp. (PVH), consensus 5.4%... Iteris (ITI), up 9.1%... H&R Block (HRB), up 1.5%. ALSO HIGHER: Bolt Technology (BOLT), up 34.8% following news that it will be acquired by Teledyne (TDY)... Tibco Software (TIBX), up 10% after announcing that it is reviewing strategic alternatives... Morgans Hotel (MHGC), up 5.1% after commenting on ongoing review of strategic alternatives. DOWN AFTER EARNINGS: Shoe Carnival (SCVL), down 7 .7%... AeroVironment (AVAV), down 5.9%. ALSO LOWER: Yum! Brands (YUM), down 3.9% after updating third quarter China division Same Store Sales guidance... Northstar Realty (NRF), down 2.3% after filing to sell 45M shares with a forward component.
17:50 EDTYUMYum! Brands drops after hours on China SSS Q3 update
Subscribe for More Information
17:46 EDTYUMYum! Brands sees China division SSS for Q3 down 13% vs. prior year
Yum! Brands made the following statement in a regulatory filing: "Since July 21st, Yum! Brands’ China division has experienced a significant, negative impact to sales at both KFC and Pizza Hut following adverse publicity regarding improper food handling practices by former supplier, Shanghai Husi, a division of OSI. As such, China division same-store sales for the third quarter ended August 31st are now estimated to be approximately -13% versus prior year. While sales are beginning to rebound, they continue to be negative. Our brands have proven resilient over time and we expect this to be the case with this situation as well. As previously reported, we will provide updated guidance on our expected full-year EPS growth on our third-quarter earnings call. The company plans to vigorously pursue legal action against OSI and Husi to recover damages from the incident."
17:25 EDTMRKMerck management to meet with SunTrust
Subscribe for More Information
12:19 EDTYUMOptions with increasing implied volatility
Subscribe for More Information
05:59 EDTSINA SINA implied volatility of 35 at lower end of index mean range
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use